<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1993-04-01" modified="2020-10-07" version="204">
<accession>P30307</accession>
<accession>D3DQB8</accession>
<accession>Q96PL3</accession>
<accession>Q9H168</accession>
<accession>Q9H2E8</accession>
<accession>Q9H2E9</accession>
<accession>Q9H2F1</accession>
<name>MPIP3_HUMAN</name>
<protein>
<recommendedName>
<fullName>M-phase inducer phosphatase 3</fullName>
<ecNumber>3.1.3.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Dual specificity phosphatase Cdc25C</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CDC25C</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="5139" last="5143">
<title>Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2.</title>
<authorList>
<person name="Sadhu K."/>
<person name="Reed B.I."/>
<person name="Richardson H."/>
<person name="Russell P."/>
</authorList>
<dbReference type="PubMed" id="2195549"/>
<dbReference type="DOI" id="10.1073/pnas.87.13.5139"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT CYS-70</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Int. J. Oncol." volume="17" first="1251" last="1258">
<title>An additional transcript of the cdc25C gene from A431 cells encodes a functional protein.</title>
<authorList>
<person name="Bureik M."/>
<person name="Rief N."/>
<person name="Drescher R."/>
<person name="Jungbluth A."/>
<person name="Montenarh M."/>
<person name="Wagner P."/>
</authorList>
<dbReference type="PubMed" id="11078813"/>
<dbReference type="DOI" id="10.3892/ijo.17.6.1251"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
</reference>
<reference key="3">
<citation type="submission" date="2003-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT CYS-70</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Eur. J. Cell Biol." volume="79" first="810" last="815">
<title>Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25C.</title>
<authorList>
<person name="Wegener S."/>
<person name="Hampe W."/>
<person name="Herrmann D."/>
<person name="Schaller H.C."/>
</authorList>
<dbReference type="PubMed" id="11139144"/>
<dbReference type="DOI" id="10.1078/0171-9335-00115"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 32-210 (ISOFORMS 2; 4 AND 5)</scope>
<scope>VARIANT CYS-70</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Lab. Invest." volume="81" first="465" last="473">
<title>Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma.</title>
<authorList>
<person name="Hernandez S."/>
<person name="Bessa X."/>
<person name="Bea S."/>
<person name="Hernandez L."/>
<person name="Nadal A."/>
<person name="Mallofre C."/>
<person name="Muntane J."/>
<person name="Castells A."/>
<person name="Fernandez P.L."/>
<person name="Cardesa A."/>
<person name="Campo E."/>
</authorList>
<dbReference type="PubMed" id="11304565"/>
<dbReference type="DOI" id="10.1038/labinvest.3780254"/>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="5989" last="6000">
<title>Activation of p34cdc2 protein kinase by microinjection of human cdc25C into mammalian cells. Requirement for prior phosphorylation of cdc25C by p34cdc2 on sites phosphorylated at mitosis.</title>
<authorList>
<person name="Strausfeld U."/>
<person name="Fernandez A."/>
<person name="Capony J.P."/>
<person name="Girard F."/>
<person name="Lautredou N."/>
<person name="Derancourt J."/>
<person name="Labbe J.C."/>
<person name="Lamb N.J."/>
</authorList>
<dbReference type="PubMed" id="8119945"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT THR-48; THR-67; SER-122; THR-130; SER-168 AND SER-214</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="6029" last="6036">
<title>The physical association and phosphorylation of Cdc25C protein phosphatase by Prk.</title>
<authorList>
<person name="Ouyang B."/>
<person name="Li W."/>
<person name="Pan H."/>
<person name="Meadows J."/>
<person name="Hoffmann I."/>
<person name="Dai W."/>
</authorList>
<dbReference type="PubMed" id="10557092"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202983"/>
</citation>
<scope>PHOSPHORYLATION BY PLK3</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Cell. Signal." volume="12" first="405" last="411">
<title>The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase.</title>
<authorList>
<person name="Roshak A.K."/>
<person name="Capper E.A."/>
<person name="Imburgia C."/>
<person name="Fornwald J."/>
<person name="Scott G."/>
<person name="Marshall L.A."/>
</authorList>
<dbReference type="PubMed" id="11202906"/>
<dbReference type="DOI" id="10.1016/s0898-6568(00)00080-2"/>
</citation>
<scope>PHOSPHORYLATION BY PLK1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="Nature" volume="411" first="102" last="107">
<title>Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase.</title>
<authorList>
<person name="Bulavin D.V."/>
<person name="Higashimoto Y."/>
<person name="Popoff I.J."/>
<person name="Gaarde W.A."/>
<person name="Basrur V."/>
<person name="Potapova O."/>
<person name="Appella E."/>
<person name="Fornace A.J. Jr."/>
</authorList>
<dbReference type="PubMed" id="11333986"/>
<dbReference type="DOI" id="10.1038/35075107"/>
</citation>
<scope>PHOSPHORYLATION AT SER-216</scope>
<scope>INTERACTION WITH MAPK14 AND 14-3-3 PROTEINS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Science" volume="299" first="1228" last="1231">
<title>Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates.</title>
<authorList>
<person name="Elia A.E."/>
<person name="Cantley L.C."/>
<person name="Yaffe M.B."/>
</authorList>
<dbReference type="PubMed" id="12595692"/>
<dbReference type="DOI" id="10.1126/science.1079079"/>
</citation>
<scope>INTERACTION WITH PLK1</scope>
<scope>PHOSPHORYLATION AT SER-129 AND THR-130</scope>
<scope>MUTAGENESIS OF SER-129 AND THR-130</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="31164" last="31170">
<title>Human SAD1 kinase is involved in UV-induced DNA damage checkpoint function.</title>
<authorList>
<person name="Lu R."/>
<person name="Niida H."/>
<person name="Nakanishi M."/>
</authorList>
<dbReference type="PubMed" id="15150265"/>
<dbReference type="DOI" id="10.1074/jbc.m404728200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-216</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="2658" last="2663">
<title>Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation.</title>
<authorList>
<person name="Bahassi el M."/>
<person name="Hennigan R.F."/>
<person name="Myer D.L."/>
<person name="Stambrook P.J."/>
</authorList>
<dbReference type="PubMed" id="14968113"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207425"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-191 AND SER-198</scope>
<scope>MUTAGENESIS OF SER-191</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Virology" volume="318" first="337" last="349">
<title>The human immunodeficiency virus Vpr protein binds Cdc25C: implications for G2 arrest.</title>
<authorList>
<person name="Goh W.C."/>
<person name="Manel N."/>
<person name="Emerman M."/>
</authorList>
<dbReference type="PubMed" id="14972559"/>
<dbReference type="DOI" id="10.1016/j.virol.2003.10.007"/>
</citation>
<scope>INTERACTION WITH HIV-1 VPR (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF GLU-352 AND LYS-359</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="Mol. Cell" volume="17" first="37" last="48">
<title>MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation.</title>
<authorList>
<person name="Manke I.A."/>
<person name="Nguyen A."/>
<person name="Lim D."/>
<person name="Stewart M.Q."/>
<person name="Elia A.E."/>
<person name="Yaffe M.B."/>
</authorList>
<dbReference type="PubMed" id="15629715"/>
<dbReference type="DOI" id="10.1016/j.molcel.2004.11.021"/>
</citation>
<scope>PHOSPHORYLATION AT SER-216 BY MAPKAPK2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Cell Cycle" volume="7" first="545" last="547">
<title>Human Plk4 phosphorylates Cdc25C.</title>
<authorList>
<person name="Bonni S."/>
<person name="Ganuelas M.L."/>
<person name="Petrinac S."/>
<person name="Hudson J.W."/>
</authorList>
<dbReference type="PubMed" id="18239451"/>
<dbReference type="DOI" id="10.4161/cc.7.4.5387"/>
</citation>
<scope>PHOSPHORYLATION BY PLK4</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64; SER-168 AND SER-472</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-61 (ISOFORMS 4 AND 5)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38; THR-48; SER-57; SER-61; SER-64 AND THR-67</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-61; SER-64 AND THR-67</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-38 AND SER-216</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<comment type="function">
<text evidence="22">Functions as a dosage-dependent inducer in mitotic control. Tyrosine protein phosphatase required for progression of the cell cycle. When phosphorylated, highly effective in activating G2 cells into prophase. Directly dephosphorylates CDK1 and activates its kinase activity.</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] + phosphate</text>
<dbReference type="Rhea" id="RHEA:10684"/>
<dbReference type="Rhea" id="RHEA-COMP:10136"/>
<dbReference type="Rhea" id="RHEA-COMP:10137"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:46858"/>
<dbReference type="ChEBI" id="CHEBI:82620"/>
<dbReference type="EC" id="3.1.3.48"/>
</reaction>
</comment>
<comment type="subunit">
<text evidence="13 14">Interacts with MAPK14 and 14-3-3 proteins. When phosphorylated on Ser-129 and/or Thr-130, interacts with PLK1.</text>
</comment>
<comment type="subunit">
<text evidence="16">(Microbial infection) Interacts with HIV-1 Vpr; this interaction inactivates CDC25C phosphatase activity.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974439">
<id>P30307</id>
</interactant>
<interactant intactId="EBI-444308">
<id>P06493</id>
<label>CDK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974439">
<id>P30307</id>
</interactant>
<interactant intactId="EBI-974488">
<id>O14757</id>
<label>CHEK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974439">
<id>P30307</id>
</interactant>
<interactant intactId="EBI-1216080">
<id>Q9Y250</id>
<label>LZTS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974439">
<id>P30307</id>
</interactant>
<interactant intactId="EBI-476768">
<id>P53350</id>
<label>PLK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-974439">
<id>P30307</id>
</interactant>
<interactant intactId="EBI-359815">
<id>P31946</id>
<label>YWHAB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="15 22">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P30307-1</id>
<name>1</name>
<name>CDC25C1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P30307-2</id>
<name>2</name>
<name>CDC25C2</name>
<sequence type="described" ref="VSP_000864"/>
</isoform>
<isoform>
<id>P30307-5</id>
<name>3</name>
<name>CDC25C3</name>
<sequence type="not described"/>
</isoform>
<isoform>
<id>P30307-3</id>
<name>4</name>
<name>CDC25C4</name>
<sequence type="described" ref="VSP_000863"/>
</isoform>
<isoform>
<id>P30307-4</id>
<name>5</name>
<name>CDC25C5</name>
<name>Cdc25Cdm</name>
<sequence type="described" ref="VSP_000863 VSP_000864"/>
</isoform>
</comment>
<comment type="developmental stage">
<text>Expressed predominantly in G2 phase.</text>
</comment>
<comment type="PTM">
<text evidence="10 12 13 15 17 19 20 22">Phosphorylated by CHEK1 and MAPK14 at Ser-216. This phosphorylation creates a binding site for 14-3-3 protein and inhibits the phosphatase. Phosphorylated by PLK4. Phosphorylated by PLK1, leading to activate the phosphatase activity. Phosphorylation by PLK3 at Ser-191 promotes nuclear translocation. Ser-198 is a minor phosphorylation site. Was initially reported to be phosphorylated by PLK3 at Ser-216 (PubMed:10557092). However, such phosphorylation by PLK3 was not confirmed by other groups. Phosphorylation at Thr-48, Thr-67, Ser-122, Thr-130, Ser-168 and Ser-214 occurs at G2 and G2-M transition and is probably catalyzed by CDK1. Ser-168 phosphorylation levels are lower than those at the other 5 CDK1 sites. Phosphorylation by CDK1 leads to increased activity.</text>
</comment>
<comment type="similarity">
<text evidence="25">Belongs to the MPI phosphatase family.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/cdc25c/"/>
</comment>
<dbReference type="EC" id="3.1.3.48"/>
<dbReference type="EMBL" id="M34065">
<property type="protein sequence ID" value="AAA35666.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ304504">
<property type="protein sequence ID" value="CAC19192.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY497474">
<property type="protein sequence ID" value="AAR32098.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW62145.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW62149.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC019089">
<property type="protein sequence ID" value="AAH19089.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF277723">
<property type="protein sequence ID" value="AAG41885.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF277725">
<property type="protein sequence ID" value="AAG41887.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF277726">
<property type="protein sequence ID" value="AAG41888.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF312681">
<property type="protein sequence ID" value="AAL26835.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4202.1">
<molecule id="P30307-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4203.1">
<molecule id="P30307-4"/>
</dbReference>
<dbReference type="PIR" id="I59168">
<property type="entry name" value="A38874"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001274511.1">
<molecule id="P30307-1"/>
<property type="nucleotide sequence ID" value="NM_001287582.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305027.1">
<property type="nucleotide sequence ID" value="NM_001318098.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001781.2">
<molecule id="P30307-1"/>
<property type="nucleotide sequence ID" value="NM_001790.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_073720.1">
<molecule id="P30307-4"/>
<property type="nucleotide sequence ID" value="NM_022809.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011542064.1">
<molecule id="P30307-4"/>
<property type="nucleotide sequence ID" value="XM_011543762.1"/>
</dbReference>
<dbReference type="PDB" id="2OJX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="E=126-134"/>
</dbReference>
<dbReference type="PDB" id="3BZI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="E=126-134"/>
</dbReference>
<dbReference type="PDB" id="3OP3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.63"/>
<property type="chains" value="A=270-462"/>
</dbReference>
<dbReference type="PDB" id="5M35">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.38"/>
<property type="chains" value="C/D=207-244"/>
</dbReference>
<dbReference type="PDB" id="5M36">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="C/D=207-244"/>
</dbReference>
<dbReference type="PDB" id="5M37">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="C/D=207-226"/>
</dbReference>
<dbReference type="PDBsum" id="2OJX"/>
<dbReference type="PDBsum" id="3BZI"/>
<dbReference type="PDBsum" id="3OP3"/>
<dbReference type="PDBsum" id="5M35"/>
<dbReference type="PDBsum" id="5M36"/>
<dbReference type="PDBsum" id="5M37"/>
<dbReference type="SMR" id="P30307"/>
<dbReference type="BioGRID" id="107430">
<property type="interactions" value="131"/>
</dbReference>
<dbReference type="DIP" id="DIP-24183N"/>
<dbReference type="IntAct" id="P30307">
<property type="interactions" value="24"/>
</dbReference>
<dbReference type="MINT" id="P30307"/>
<dbReference type="STRING" id="9606.ENSP00000321656"/>
<dbReference type="BindingDB" id="P30307"/>
<dbReference type="ChEMBL" id="CHEMBL2378"/>
<dbReference type="DrugCentral" id="P30307"/>
<dbReference type="DEPOD" id="CDC25C"/>
<dbReference type="iPTMnet" id="P30307"/>
<dbReference type="PhosphoSitePlus" id="P30307"/>
<dbReference type="BioMuta" id="CDC25C"/>
<dbReference type="DMDM" id="116242631"/>
<dbReference type="EPD" id="P30307"/>
<dbReference type="jPOST" id="P30307"/>
<dbReference type="MassIVE" id="P30307"/>
<dbReference type="PaxDb" id="P30307"/>
<dbReference type="PeptideAtlas" id="P30307"/>
<dbReference type="PRIDE" id="P30307"/>
<dbReference type="ProteomicsDB" id="54658">
<molecule id="P30307-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54659">
<molecule id="P30307-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54660">
<molecule id="P30307-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54661">
<molecule id="P30307-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="3534">
<property type="antibodies" value="1067 antibodies"/>
</dbReference>
<dbReference type="CPTC" id="P30307">
<property type="antibodies" value="1 antibody"/>
</dbReference>
<dbReference type="DNASU" id="995"/>
<dbReference type="Ensembl" id="ENST00000323760">
<molecule id="P30307-1"/>
<property type="protein sequence ID" value="ENSP00000321656"/>
<property type="gene ID" value="ENSG00000158402"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000348983">
<molecule id="P30307-4"/>
<property type="protein sequence ID" value="ENSP00000345205"/>
<property type="gene ID" value="ENSG00000158402"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000415130">
<molecule id="P30307-4"/>
<property type="protein sequence ID" value="ENSP00000392631"/>
<property type="gene ID" value="ENSG00000158402"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000513970">
<molecule id="P30307-1"/>
<property type="protein sequence ID" value="ENSP00000424795"/>
<property type="gene ID" value="ENSG00000158402"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000514555">
<molecule id="P30307-2"/>
<property type="protein sequence ID" value="ENSP00000425470"/>
<property type="gene ID" value="ENSG00000158402"/>
</dbReference>
<dbReference type="GeneID" id="995"/>
<dbReference type="KEGG" id="hsa:995"/>
<dbReference type="UCSC" id="uc003lcp.3">
<molecule id="P30307-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="995"/>
<dbReference type="DisGeNET" id="995"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000158402.18"/>
<dbReference type="GeneCards" id="CDC25C"/>
<dbReference type="HGNC" id="HGNC:1727">
<property type="gene designation" value="CDC25C"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000158402">
<property type="expression patterns" value="Group enriched (lymphoid tissue, testis)"/>
</dbReference>
<dbReference type="MIM" id="157680">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P30307"/>
<dbReference type="OpenTargets" id="ENSG00000158402"/>
<dbReference type="PharmGKB" id="PA100"/>
<dbReference type="eggNOG" id="KOG3772">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000161460"/>
<dbReference type="HOGENOM" id="CLU_014464_4_0_1"/>
<dbReference type="InParanoid" id="P30307"/>
<dbReference type="KO" id="K05867"/>
<dbReference type="OMA" id="SKAWEGE"/>
<dbReference type="OrthoDB" id="1423329at2759"/>
<dbReference type="PhylomeDB" id="P30307"/>
<dbReference type="TreeFam" id="TF101056"/>
<dbReference type="BRENDA" id="3.1.3.48">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P30307"/>
<dbReference type="Reactome" id="R-HSA-156711">
<property type="pathway name" value="Polo-like kinase mediated events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176187">
<property type="pathway name" value="Activation of ATR in response to replication stress"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5625740">
<property type="pathway name" value="RHO GTPases activate PKNs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804114">
<property type="pathway name" value="TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804115">
<property type="pathway name" value="TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69273">
<property type="pathway name" value="Cyclin A/B1/B2 associated events during G2/M transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75035">
<property type="pathway name" value="Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8862803">
<property type="pathway name" value="Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models"/>
</dbReference>
<dbReference type="SIGNOR" id="P30307"/>
<dbReference type="BioGRID-ORCS" id="995">
<property type="hits" value="5 hits in 881 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CDC25C">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P30307"/>
<dbReference type="GeneWiki" id="CDC25C"/>
<dbReference type="GenomeRNAi" id="995"/>
<dbReference type="Pharos" id="P30307">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P30307"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="P30307">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000158402">
<property type="expression patterns" value="Expressed in ventricular zone and 113 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P30307">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P30307">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005758">
<property type="term" value="C:mitochondrial intermembrane space"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004725">
<property type="term" value="F:protein tyrosine phosphatase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050699">
<property type="term" value="F:WW domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell population proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006977">
<property type="term" value="P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010971">
<property type="term" value="P:positive regulation of G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0110032">
<property type="term" value="P:positive regulation of G2/MI transition of meiotic cell cycle"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045931">
<property type="term" value="P:positive regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000079">
<property type="term" value="P:regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007088">
<property type="term" value="P:regulation of mitotic nuclear division"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007283">
<property type="term" value="P:spermatogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd01530">
<property type="entry name" value="Cdc25"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP02126"/>
<dbReference type="Gene3D" id="3.40.250.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00198"/>
<dbReference type="InterPro" id="IPR000751">
<property type="entry name" value="MPI_Phosphatase"/>
</dbReference>
<dbReference type="InterPro" id="IPR001763">
<property type="entry name" value="Rhodanese-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036873">
<property type="entry name" value="Rhodanese-like_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF06617">
<property type="entry name" value="M-inducer_phosp"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00581">
<property type="entry name" value="Rhodanese"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00716">
<property type="entry name" value="MPIPHPHTASE"/>
</dbReference>
<dbReference type="SMART" id="SM00450">
<property type="entry name" value="RHOD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52821">
<property type="entry name" value="SSF52821"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50206">
<property type="entry name" value="RHODANESE_3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0904">Protein phosphatase</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="initiator methionine" description="Removed" evidence="6">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="M-phase inducer phosphatase 3" id="PRO_0000198647">
<location>
<begin position="2"/>
<end position="473"/>
</location>
</feature>
<feature type="domain" description="Rhodanese" evidence="9">
<location>
<begin position="321"/>
<end position="428"/>
</location>
</feature>
<feature type="region of interest" description="HIV-1 Vpr binding site">
<location>
<begin position="334"/>
<end position="379"/>
</location>
</feature>
<feature type="active site" evidence="8">
<location>
<position position="377"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="6">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 7">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3 22">
<location>
<position position="48"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="57"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5">
<location>
<position position="61"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 5">
<location>
<position position="64"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3 5 22">
<location>
<position position="67"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1" evidence="26">
<location>
<position position="122"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="129"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14">
<location>
<position position="130"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 22">
<location>
<position position="168"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PLK3" evidence="15">
<location>
<position position="191"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PLK3" evidence="15">
<location>
<position position="198"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1" evidence="26">
<location>
<position position="214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CHEK1, CHEK2, BRSK1 and MAPK14" evidence="7 13 17 19">
<location>
<position position="216"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="472"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4 and isoform 5." id="VSP_000863" evidence="23 24">
<original>GTPKRCLDLSNLSSGEITATQLTTSADLDETGHLDSSGLQEVHLAGMNHDQHLMKCSP</original>
<variation>SPGFFRTSGSAFSWD</variation>
<location>
<begin position="66"/>
<end position="123"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 5." id="VSP_000864" evidence="23 24">
<location>
<begin position="124"/>
<end position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11567959." id="VAR_027922">
<original>S</original>
<variation>N</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3734166." id="VAR_027923" evidence="11 18 21">
<original>R</original>
<variation>C</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11567962." id="VAR_027924">
<original>S</original>
<variation>N</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11567997." id="VAR_020146">
<original>G</original>
<variation>R</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation. Severely impairs PLK1-binding." evidence="14">
<original>S</original>
<variation>V</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation. Severely impairs PLK1-binding." evidence="14">
<original>T</original>
<variation>A</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="mutagenesis site" description="Facilitates nuclear exclusion." evidence="15">
<original>S</original>
<variation>A</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimicks phosphorylation state, leading to enhanced accumulation in the nucleus." evidence="15">
<original>S</original>
<variation>D</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of HIV-1 Vpr binding." evidence="16">
<original>E</original>
<variation>K</variation>
<location>
<position position="352"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on HIV-1 Vpr binding." evidence="16">
<original>K</original>
<variation>E</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="127"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="286"/>
<end position="289"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="300"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="307"/>
<end position="314"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="315"/>
<end position="321"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="322"/>
<end position="329"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="333"/>
<end position="337"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="339"/>
<end position="341"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="350"/>
<end position="357"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="369"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="384"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="409"/>
<end position="412"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="415"/>
<end position="419"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="420"/>
<end position="422"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="424"/>
<end position="426"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="427"/>
<end position="430"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="438"/>
<end position="440"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location sequence="P30307-3">
<position position="61"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location sequence="P30307-4">
<position position="61"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BZI"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OP3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00173"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10557092"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11139144"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11202906"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11333986"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12595692"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14968113"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14972559"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15150265"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15629715"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18239451"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2195549"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8119945"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11078813"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11139144"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305"/>
<evidence key="26" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="8119945"/>
</source>
</evidence>
<sequence length="473" mass="53365" checksum="0658A1F1B9B8996A" modified="2006-10-17" version="2">MSTELFSSTREEGSSGSGPSFRSNQRKMLNLLLERDTSFTVCPDVPRTPVGKFLGDSANLSILSGGTPKRCLDLSNLSSGEITATQLTTSADLDETGHLDSSGLQEVHLAGMNHDQHLMKCSPAQLLCSTPNGLDRGHRKRDAMCSSSANKENDNGNLVDSEMKYLGSPITTVPKLDKNPNLGEDQAEEISDELMEFSLKDQEAKVSRSGLYRSPSMPENLNRPRLKQVEKFKDNTIPDKVKKKYFSGQGKLRKGLCLKKTVSLCDITITQMLEEDSNQGHLIGDFSKVCALPTVSGKHQDLKYVNPETVAALLSGKFQGLIEKFYVIDCRYPYEYLGGHIQGALNLYSQEELFNFFLKKPIVPLDTQKRIIIVFHCEFSSERGPRMCRCLREEDRSLNQYPALYYPELYILKGGYRDFFPEYMELCEPQSYCPMHHQDHKTELLRCRSQSKVQEGERQLREQIALLVKDMSP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

